Prosapogenin CP4 and ursolic acid from Eriocapitella rivularis inhibit fluconazole-resistant Candida albicans synergistically by regulating Ras/cAMP/PKA pathway
Phytomedicine · 2026
DOI: 10.1016/j.phymed.2026.158142 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytomedicine, 2026. Verfasst von Wen-Biao Zu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Yunnan Characteristic Plant Extraction Laboratory, Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education and Yunnan Provi…. Hauptthemen laut MEDLINE: Candida albicans, Antifungal Agents, Triterpenes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Yunnan University, National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Fungal diseases affect over one billion individuals worldwide and represent a significant public health concern. Oral candidiasis (OC) is a common fungal infection primarily caused by Candida albicans. Eriocapitella rivularis is a traditional medicinal herb for the treatment of oral fungal infections. PURPOSE: This study aimed to identify potent antifungal compounds from E. rivularis and elucidate their underlying mechanisms of action. METHODS: Bio-guided isolation combined with network pharmacology was used to identify anti-C. albicans compounds from E. rivularis, followed by metabolomics analysis to explore potential regulatory pathways. Antifungal activity and synergistic efficacy were evaluated using broth microdilution, checkerboard, and time-kill assays. Biofilm inhibition was assessed through quantitative and biochemical analyses. Reverse transcription quantitative polymerase chain reaction was performed to elucidate molecular mechanisms. An in vivo murine OC model was employed to verify efficacy. RESULTS: Prosapogenin CP4 disrupted the fungal cell wall, targeted ergosterol to induce plasma membrane permeabilization, inactivated mitochondrial function, and inhibited hyphal growth, potentially through interference with ABC transporters, modulation of cAMP export, and induction of metabolic disorders. Prosapogenin CP4 and ursolic acid exhibited a synergistic inhibitory effect against fluconazole-resistant C. albicans (FICI = 0.375) with low resistance. This combination regulated genes in the Ras/cAMP/PKA signalling pathway, significantly inhibited biofilm formation and reduced fungal burden, inflammatory responses, and fungal colonisation in murine oral tissues, with efficacy comparable or superior to that of nystatin. CONCLUSION: The finding presents a synergistic phytomedicine strategy using two triterpenoids from E. rivularis as a promising therapeutic approach for OC, particularly biofilm-associated infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Yunnan Characteristic Plant Extraction Laboratory, Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education and Yunnan Province, School of Chemical Science and Technology, Yunnan University, Kun…
Förderung
- Yunnan University
- National Natural Science Foundation of China
Zitieren
APA
Zu, W. B., Wang, Z. J., Tang, D. M., Lu, Q. Y., Zhu, Y. Y., Zhou, Z. S., Wei, M. Z., & Luo, X. D. (2026). Prosapogenin CP4 and ursolic acid from Eriocapitella rivularis inhibit fluconazole-resistant Candida albicans synergistically by regulating Ras/cAMP/PKA pathway. Phytomedicine. https://doi.org/10.1016/j.phymed.2026.158142
Vancouver
Zu WB, Wang ZJ, Tang DM, Lu QY, Zhu YY, Zhou ZS, et al. Prosapogenin CP4 and ursolic acid from Eriocapitella rivularis inhibit fluconazole-resistant Candida albicans synergistically by regulating Ras/cAMP/PKA pathway. Phytomedicine. 2026. doi:10.1016/j.phymed.2026.158142
BibTeX
@article{Zu2026,
author = {Zu, Wen-Biao and Wang, Zhao-Jie and Tang, Dong-Mei and Lu, Qin-Yu and Zhu, Yan-Yan and Zhou, Zhong-Shun and Wei, Mei-Zhen and Luo, Xiao-Dong},
title = {Prosapogenin CP4 and ursolic acid from Eriocapitella rivularis inhibit fluconazole-resistant Candida albicans synergistically by regulating Ras/cAMP/PKA pathway},
journal = {Phytomedicine},
year = {2026},
doi = {10.1016/j.phymed.2026.158142}
}
EUVIMED